Daniel M. Kolansky

4.2k total citations
66 papers, 2.4k citations indexed

About

Daniel M. Kolansky is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel M. Kolansky has authored 66 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 26 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel M. Kolansky's work include Coronary Interventions and Diagnostics (13 papers), Acute Myocardial Infarction Research (13 papers) and Cardiac, Anesthesia and Surgical Outcomes (11 papers). Daniel M. Kolansky is often cited by papers focused on Coronary Interventions and Diagnostics (13 papers), Acute Myocardial Infarction Research (13 papers) and Cardiac, Anesthesia and Surgical Outcomes (11 papers). Daniel M. Kolansky collaborates with scholars based in United States, Canada and Japan. Daniel M. Kolansky's co-authors include Daniel J. Rader, James M. Wilson, Bernard J. Clark, Barry D. Fuchs, David F. Gaieski, Benjamin S. Abella, Evan A. Stein, Steven E. Raper, David W.M. Muller and Mariann Grossman and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Medicine.

In The Last Decade

Daniel M. Kolansky

63 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel M. Kolansky United States 26 998 978 411 345 339 66 2.4k
Aun‐Yeong Chong Canada 24 717 0.7× 1.3k 1.3× 126 0.3× 282 0.8× 309 0.9× 100 2.1k
Jari Laurikka Finland 25 947 0.9× 662 0.7× 284 0.7× 361 1.0× 180 0.5× 131 2.1k
Diem Dinh Australia 24 820 0.8× 1.8k 1.9× 185 0.5× 298 0.9× 195 0.6× 169 2.4k
Hoong Sern Lim United Kingdom 25 625 0.6× 1.1k 1.1× 275 0.7× 214 0.6× 309 0.9× 122 2.2k
Axel Schlitt Germany 31 1.0k 1.0× 1.5k 1.6× 369 0.9× 267 0.8× 558 1.6× 143 3.5k
Marco Tubaro Italy 27 1.1k 1.1× 2.4k 2.4× 295 0.7× 566 1.6× 185 0.5× 89 3.4k
Troels Thim Denmark 23 814 0.8× 782 0.8× 169 0.4× 290 0.8× 222 0.7× 99 1.7k
François Roubille France 27 520 0.5× 1.4k 1.5× 390 0.9× 208 0.6× 523 1.5× 215 2.9k
Magda Heras Spain 32 770 0.8× 2.5k 2.5× 127 0.3× 264 0.8× 355 1.0× 169 3.5k
Wayne Tymchak Canada 23 566 0.6× 1.5k 1.6× 143 0.3× 786 2.3× 184 0.5× 65 2.4k

Countries citing papers authored by Daniel M. Kolansky

Since Specialization
Citations

This map shows the geographic impact of Daniel M. Kolansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Kolansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Kolansky more than expected).

Fields of papers citing papers by Daniel M. Kolansky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel M. Kolansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Kolansky. The network helps show where Daniel M. Kolansky may publish in the future.

Co-authorship network of co-authors of Daniel M. Kolansky

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel M. Kolansky. A scholar is included among the top collaborators of Daniel M. Kolansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel M. Kolansky. Daniel M. Kolansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kohan, Donald E., John J.V. McMurray, George L. Bakris, et al.. (2022). Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure. JACC Heart Failure. 10(7). 498–507. 11 indexed citations
2.
Naidu, Srihari S., J. Dawn Abbott, James C. Blankenship, et al.. (2021). SCAI expert consensus update on best practices in the cardiac catheterization laboratory. Catheterization and Cardiovascular Interventions. 98(2). 255–276. 30 indexed citations
3.
Fearon, William F., Stephan Achenbach, Thomas Engstrøm, et al.. (2019). Accuracy of Fractional Flow Reserve Derived From Coronary Angiography. Circulation. 139(4). 477–484. 149 indexed citations
4.
Selvaraj, Senthil, Sheela Krishnan, Mahesh Vidula, et al.. (2019). VARIATION IN EMERGENCY DEPARTMENT PROVIDER ORDERING, TIME TO DISCHARGE, AND OUTCOMES IN ANATOMIC VERSUS FUNCTIONAL STRESS TESTING FOR RISK STRATIFICATION OF PATIENTS PRESENTING WITH CHEST DISCOMFORT. Journal of the American College of Cardiology. 73(9). 1556–1556.
5.
Maheshwari, Ankit, Nimesh D. Desai, Jay Giri, et al.. (2019). Use of Intracardiac Echocardiography During Transvenous Lead Extraction to Avoid a Catastrophic Injury. JACC. Clinical electrophysiology. 5(6). 744–745. 6 indexed citations
6.
Seto, Arnold H., Adhir Shroff, Mazen Abu‐Fadel, et al.. (2018). Length of stay following percutaneous coronary intervention: An expert consensus document update from the society for cardiovascular angiography and interventions. Catheterization and Cardiovascular Interventions. 92(4). 717–731. 58 indexed citations
7.
Khatana, Sameed Ahmed M., Paul N. Fiorilli, Ashwin S. Nathan, et al.. (2018). Association Between 30-Day Mortality After Percutaneous Coronary Intervention and Education and Certification Variables for New York State Interventional Cardiologists. Circulation Cardiovascular Interventions. 11(9). e006094–e006094. 5 indexed citations
8.
Volpp, Kevin G., Andrea B. Troxel, Shivan J. Mehta, et al.. (2017). Effect of Electronic Reminders, Financial Incentives, and Social Support on Outcomes After Myocardial Infarction. JAMA Internal Medicine. 177(8). 1093–1093. 105 indexed citations
9.
Troxel, Andrea B., David A. Asch, Shivan J. Mehta, et al.. (2016). Rationale and design of a randomized trial of automated hovering for post–myocardial infarction patients: The HeartStrong program. American Heart Journal. 179. 166–174. 12 indexed citations
10.
Kadakia, Mitul B., Sunil V. Rao, Lisa A. McCoy, et al.. (2015). Transradial Versus Transfemoral Access in Patients Undergoing Rescue Percutaneous Coronary Intervention After Fibrinolytic Therapy. JACC: Cardiovascular Interventions. 8(14). 1868–1876. 15 indexed citations
11.
Giri, Jay, et al.. (2014). CORONARY ARTERY ANEURYSMS ASSOCIATED WITH ASCENDING AORTIC ANEURYSMS AND ABDOMINAL AORTIC ANEURYSMS: PATHOPHYSIOLOGIC IMPLICATIONS. Journal of the American College of Cardiology. 63(12). A1844–A1844. 1 indexed citations
12.
Ratcliffe, Sarah J., et al.. (2010). Predictors of Complications Following Sheath Removal With Percutaneous Coronary Intervention. The Journal of Cardiovascular Nursing. 25(3). E1–E8. 19 indexed citations
13.
Khatri, Pooja, Robert A. Taylor, Vanessa Palumbo, et al.. (2008). The Safety and Efficacy of Thrombolysis for Strokes After Cardiac Catheterization. Journal of the American College of Cardiology. 51(9). 906–911. 35 indexed citations
14.
Kolansky, Daniel M., Marina Cuchel, Bernard J. Clark, et al.. (2008). Longitudinal Evaluation and Assessment of Cardiovascular Disease in Patients With Homozygous Familial Hypercholesterolemia. The American Journal of Cardiology. 102(11). 1438–1443. 132 indexed citations
15.
Kolansky, Daniel M., et al.. (2006). Prophylaxis Against Venous Thromboembolism in Acutely Ill Medical Patients: An Observational Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(8). 1086–1090. 9 indexed citations
16.
Herrmann, Howard C., Tomasz A. Swierkosz, Shiv Kapoor, et al.. (2002). Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non–Q-wave myocardial infarction undergoing percutaneous coronary intervention. The American Journal of Cardiology. 89(11). 1293–1297. 31 indexed citations
17.
Klugherz, Bruce D., Nicolas Méneveau, Daniel M. Kolansky, et al.. (2000). Predictors of clinical outcome following percutaneous intervention for in-stent restenosis. The American Journal of Cardiology. 85(12). 1427–1431. 12 indexed citations
18.
Kolansky, Daniel M., et al.. (2000). Combination therapy with clopidogrel and aspirin after coronary stenting. Catheterization and Cardiovascular Interventions. 50(3). 276–279. 14 indexed citations
19.
Wiegers, Susan E., Bernard J. Clark, James M. Wilson, et al.. (1996). Stress echocardiography in children with homozygous familial hypercholesterolemia predicts severe coronary artery disease. Journal of the American College of Cardiology. 27(2). 262–262. 1 indexed citations
20.
Kolansky, Daniel M., et al.. (1991). High affinity ouabain binding of the alpha 2 isoform of Na,K-ATPase in transfected mammalian cells. Journal of the American College of Cardiology. 17(2). A140–A140. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026